1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Luis Nacul: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-dose Naltrexone for Post-COVID Fatigue Syndrome Low-Dose Naltrexone, Placebo - Post-Viral Fatigue Syndrome | Phase 2 | Completed | Luis Nacul | 160 | 2024-01-15 | 2026-03-20 |
COVID-19 (1) · Fatigue Syndrome, Chronic (1) · Post-Acute COVID-19 Syndrome (1)
Naltrexone (1)
Canada (1)